11-474 - MOLARIS-XG Software

Description:

More information available from the Warshel Center for Multiscale Simulations

Developed by Nobel Laureate Arieh Warshel, MOLARIS-XG is a specialized computational chemistry and molecular simulation software package that helps scientists model and predict how biomolecules behave, especially proteins, enzymes, and drug candidates. 

The software is especially valued in:

  • Drug discovery — predicting how strongly a drug binds to a target protein and estimating reaction energetics before expensive lab experiments. 
  • Enzyme research — studying catalytic mechanisms and mutation effects using Empirical Valence Bond (EVB) methods, one of the areas Arieh Warshel pioneered. 
  • Protein energetics — calculating pKa values, electrostatics, redox potentials, ligand binding energies, and conformational changes. 
  • QM/MM simulations — combining quantum mechanics and molecular mechanics to model chemical reactions inside biological systems. 
  • Coarse-grained simulations — allowing researchers to study larger biomolecular systems more efficiently than full atomistic simulations. 

Benefits

  • Relative to more general molecular dynamics packages, MOLARIS-XG has a strong focus on enzyme catalysis and electrostatic effects, which are critical in biochemical reactions.
  • Integrates methods like EVB, PDLD, FEP, and LRA into one platform.

Applications

  • Design better enzymes
  • Predict mutation effects
  • Optimize drug candidates
  • Model ion channels and GPCRs
  • Study reaction pathways that are difficult to observe experimentally

Stage of Development

  • Available for non-exclusive licensing

Patent Information: